Human medicines European public assessment report (EPAR): Brinsupri, Brensocatib, Date of authorisation: 18/11/2025, Revision: 1, Status: Authorised

List of eligible industry stakeholder organisations

Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation: 30/10/2023, Revision: 5, Status: Authorised

Nominations to the Network Portfolio Advisory Group

Human medicines European public assessment report (EPAR): Trodelvy, sacituzumab govitecan, Date of authorisation: 22/11/2021, Revision: 8, Status: Authorised

Medicinal products for human use: monthly figures - August 2026

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, European Medicines Agency, Amsterdam, the Netherlands, from 15 September 2026, 09:30 (CEST) to 15 September 2026, 13:30 (CEST)

Human medicines European public assessment report (EPAR): Bekemv, eculizumab, Date of authorisation: 19/04/2023, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Camcevi, leuprorelin, Date of authorisation: 24/05/2022, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): DuoPlavin, clopidogrel,acetylsalicylic acid, Date of authorisation: 14/03/2010, Revision: 32, Status: Authorised